戻る Agenda
Session 4: Report Back from the Roundtable Discussions (Sessions 2 and 3) & Panel Discussion
Session Chair(s)
Niklas Hedberg, MPHARM
HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
In this session, the facilitators of the various roundtable discussions will share the main conclusions and any identified next steps from their table. A Panel composed by representatives of the various stakeholders will comment the conclusions shared and provide further insights into next steps and their work plan for 2024.
Speaker(s)
Niklas Hedberg, MPHARM
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
HTACG Co-Chair & Chief Pharmacist
Francesca Cerreta, PHARMD, MPHARM, MS
European Medicines Agency, Netherlands
Principal Scientific Officer
Alexander Natz, JD
European Confederation of Pharmaceutical Entrepreneurs, Belgium
Secretary General
Ansgar Hebborn, PHD, MBA
F. Hoffmann-La Roche AG, Switzerland
Head - Access Policy Affairs Europe